Drug intelligence / Profile preview

paracetamol + methionine

Development stage
Unknown
Lead developer
Equity Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Paradote is a fixed-dose combination pharmaceutical product containing the analgesic and antipyretic **paracetamol** (acetaminophen) and the amino acid **methionine**. It is primarily indicated for the relief of mild to moderate pain and fever. The inclusion of methionine serves as a hepatoprotective strategy; methionine is a metabolic precursor to glutathione, which is the primary endogenous antioxidant required to detoxify N-acetyl-p-benzoquinone imine (NAPQI), the toxic metabolite of paracetamol. In the event of an overdose, NAPQI depletes hepatic glutathione stores, leading to liver necrosis. By providing supplemental methionine, Paradote helps maintain or replenish glutathione levels, thereby reducing the risk of severe liver damage. The drug is distributed by Equity Pharmaceuticals, particularly within their hospital division in South Africa.

Brand names
Paradote
Other names
acetaminophen + methionineparacetamol and methionine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ABCB11 (Bile salt export pump)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + methionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + methionine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call